Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 1 Gallbladder Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Carboplatin 71 pembrolizumab 70 Pemetrexed 62 Cisplatin 46 Nivolumab 28 Paclitaxel 27 durvalumab 26 Specimen Handling 25 osimertinib 23 Docetaxel 23 Magnetic Resonance Spectroscopy 21 Gemcitabine 17 Cetuximab 15 130-nm albumin-bound paclitaxel 15 atezolizumab 14 amivantamab 14 Radiotherapy 12 Radiosurgery 12 lazertinib 11 Ipilimumab 9 Bevacizumab 9 cemiplimab 8 Taxes 8 Drug Therapy 8 alectinib 7 Ramucirumab 7 Observation 7 Radiation 6 Leucovorin 5 Immunoglobulin G 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × guadecitabine × 30 days × Clear all

NCT02998567 2026-05-12

HyPeR

Royal Marsden NHS Foundation Trust

Phase 1 Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡